Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isodiol International Inc ISOLF

Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures; Capsules; Topicals; Vape; Oral Spray; Skincare; and others.


GREY:ISOLF - Post by User

Bullboard Posts
Comment by jb24on Sep 04, 2018 4:16pm
14 Views
Post# 28561343

RE:RE:RE:Scientists at the UK MHRA, Brazil`s Anvisa, and Germany GMP

RE:RE:RE:Scientists at the UK MHRA, Brazil`s Anvisa, and Germany GMPAPI alone is worth $20.00 ps -looking forword--never mind the  20,000 kilos/yr at 10k coming next year.gltals


bambambigelo wrote: WOW, THAT;S PATHETUIC RUNNER, PLEASE NAME THE OTHER COMAPNY YOU CAN GET 99.5 % PURE CBD ISOLATE FROM, NO ONE ELSE HAS THE DESIGNATION.  HERE IS THE NEWS RELEASE IN REGARDS TO API GRADE CBD. IT SAYS NOTHING ABOUT HEMP OIL. 

Isodiol International Inc. (CSE: C.ISOLOTC: ISOLFForum) said Thursday its wholly-owned subsidiary BSPG Laboratories Ltd. has received government approval from the United Kingdom’s Medicines and Healthcare Regulatory Agency (MHRA), in accordance with The Human Medicines Regulations 2012, for the manufacturing of the active substance Cannabidiol under the certificate number: UK API 48727.

MHRA is an executive agency of the United Kingdom’s Department of Health and the regulatory agency that regulates medicines and medical devices.

“The approval validates the quality of our pure, natural CBD isolate and patented manufacturing process,’’ said Marcos Agramont, CEO of Isodiol.

With MHRA approval and because it meets all regulatory requirements under international law, the company is now able to export the pure, natural CBD anywhere in the world, subject to pharmaceutical regulations.

More information can be found here.

Isodiol is a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and nutraceutical products.

Isodiol was in the news recently when the company announced fiscal 2018 Q2 revenues of its wholly-owned subsidiary ISO International LLC.

Read more at https://www.stockhouse.com/news/newswire/2018/04/26/isodiol-receives-u-k-approval-to-manufacture-cannabidiol#VqRZRRyVKmIS2f5v.99


Bullboard Posts